On November 30 to December 01, 2011, AO “Pharm-Sintez” participated in the II National Congress “Emergency Conditions in Neurology” held in the Moscow City Government Building. The Company successfully promoted its innovative neuroprotector Cellex®, scheduled to come to the pharmaceutical market in the early 2012. The event has attracted considerable attention of the Congress participants.
During the Congress “Pharm-Sintez” representatives talked with attending doctors, explaining clinical study results and unique effect of the Cellex® product.
On the second day of the Congress, as part of the “Neuroprotection” symposium, was presented report “Neuroprotective properties of new tissue-specific embryonic protein-polypeptide complex, based on the pre-clinical and clinical study results”. Many doctors from CIS countries listened to the report and with interest discussed prospects of using new, unique product in their practice.